- Home
- GNRC vs BRKR Comparison
GNRC vs BRKR Comparison
Compare GNRC & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNRC | BRKR |
|---|---|---|
| Founded | 1959 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9B | 7.0B |
| IPO Year | 2010 | 2000 |
Fundamental Metrics
Financial Performance| Metric | GNRC | BRKR |
|---|---|---|
| Price | $140.84 | $48.04 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 13 |
| Target Price | ★ $192.05 | $49.42 |
| AVG Volume (30 Days) | 1.0M | ★ 2.1M |
| Earning Date | 02-11-2026 | 02-12-2026 |
| Dividend Yield | N/A | ★ 0.42% |
| EPS Growth | ★ 9.08 | N/A |
| EPS | ★ 5.26 | N/A |
| Revenue | ★ $4,352,444,000.00 | $3,438,900,000.00 |
| Revenue This Year | $2.01 | $3.55 |
| Revenue Next Year | $11.11 | $1.49 |
| P/E Ratio | $26.79 | ★ N/A |
| Revenue Growth | 5.52 | ★ 6.10 |
| 52 Week Low | $99.50 | $28.53 |
| 52 Week High | $203.25 | $64.64 |
Technical Indicators
Market Signals| Indicator | GNRC | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 37.30 | 59.74 |
| Support Level | $134.80 | $47.52 |
| Resistance Level | $141.54 | $49.15 |
| Average True Range (ATR) | 6.17 | 1.71 |
| MACD | -1.53 | -0.05 |
| Stochastic Oscillator | 17.11 | 75.01 |
Price Performance
Historical ComparisonAbout GNRC Generac Holdlings Inc.
Generac designs and manufactures power generation equipment serving residential, commercial, and industrial markets. It offers standby generators, portable generators, lighting, outdoor power equipment, and a suite of clean energy products. Sales generated in the United States account for the majority of total sales.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.